Medivation | THE "NEW" PROSTATE CANCER INFOLINK

Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
A service of

Prostate Cancer International.
Awards
Other PCI web sites

El Cáncer de Próstata Latinoamérica
Prostate Cancer Africa
Prostate Cancer Caribbean
Solidarité Prostate InfoLink
Copyright © 2008-18 Prostate Cancer International, Inc.

Pfizer completes acquisition of Medivation

Posted on September 28, 2016 by Sitemaster

As of midnight last night, Pfizer completed the acquisition of Medivation and therefore enzalutamide (Xtandi) is now being sold in the USA by Pfizer and Astellas and by Astellas in the rest of the world. For the details, see here.

Filed under: Uncategorized | Tagged: enzalutamide, Medivation, Pfizer, Xtandi | 1 Comment »

A “shopping war” for Medivation?

Posted on May 4, 2016 by Sitemaster

It appears that the major pharma companies have initiated yet another merger frenzy, with at least two companies expressing interest in acquiring Medivation (the company that developed enzalutamide/Xtandi). … READ MORE …

Filed under: Uncategorized | Tagged: acquisition, Medivation, merger, target | Leave a comment »

THE "NEW" PROSTATE CANCER INFOLINK

A service of

Awards

Other PCI web sites

Pfizer completes acquisition of Medivation

A “shopping war” for Medivation?

Disclaimer

Hot Posts …

… and Archives